NCS-382
Jump to navigation
Jump to search
Template:Short description Template:Cs1 config
NCS-382 is a moderately selective antagonist for the GHB receptor.[1][2] It blocks the effects of GHB in animals and has both anti-sedative and anticonvulsant effects.[3][4][5] It has been proposed as a treatment for GHB overdose in humans as well as the genetic metabolic disorder succinic semialdehyde dehydrogenase deficiency (SSADHD), but has never been developed for clinical use.[6]
References
<templatestyles src="Reflist/styles.css" />
Script error: No such module "Check for unknown parameters".